Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert F Spiera

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Current Rheumatology Reports|August 20, 2013
Biomarkers in ANCA-associated vasculitisLindsay Lally, Robert F Spiera
Arthritis and Rheumatism|September 30, 2006
Therapy for giant cell arteritis: can we do better?Robert F Spiera, Harry Spiera
Rheumatic Diseases Clinics of North America|April 4, 2015
Pulmonary vasculitisLindsay Lally, Robert F Spiera
Rheumatic Diseases Clinics of North America|July 7, 2019
Treatment of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Is There Still a Role for Cyclophosphamide?Sebastian E Sattui, Robert F Spiera
Current Opinion in Rheumatology|September 10, 2010
Targeting tyrosine kinases: a novel therapeutic strategy for systemic sclerosisJessica K Gordon, Robert F Spiera
Annals of Internal Medicine|September 17, 2002
Long-term outcome in lupus nephritisRobert F Spiera, Peter Homel, Harry Spiera
Arthritis and Rheumatism|April 11, 2003
Vision loss in giant cell arteritis patients treated with alternate-day corticosteroids: comment on the article by Hoffman et alRobert F Spiera, Mark Kupersmith, Stephen Paget, et al.
Clinical and Experimental Rheumatology|May 24, 2014
Practice patterns of ANCA-associated vasculitis: exploring differences among subspecialties at a single academic medical centreLindsy J Forbess, Kenneth W Griffin, Robert F Spiera
Arthritis Care & Research|October 10, 2014
Effectiveness of rituximab for the otolaryngologic manifestations of granulomatosis with polyangiitis (Wegener's)Lindsay Lally, Robert S Lebovics, Wei-Ti Huang, et al.
Archives of Internal Medicine|October 24, 2002
Ticlopidine-induced lupus: a report of 4 casesRobert F Spiera, Rosanne S Berman, Andrew J Werner, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Current Rheumatology Reports|August 20, 2013
Biomarkers in ANCA-associated vasculitisLindsay Lally, Robert F Spiera
Arthritis and Rheumatism|September 30, 2006
Therapy for giant cell arteritis: can we do better?Robert F Spiera, Harry Spiera
Rheumatic Diseases Clinics of North America|April 4, 2015
Pulmonary vasculitisLindsay Lally, Robert F Spiera
Rheumatic Diseases Clinics of North America|July 7, 2019
Treatment of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Is There Still a Role for Cyclophosphamide?Sebastian E Sattui, Robert F Spiera
Current Opinion in Rheumatology|September 10, 2010
Targeting tyrosine kinases: a novel therapeutic strategy for systemic sclerosisJessica K Gordon, Robert F Spiera
Annals of Internal Medicine|September 17, 2002
Long-term outcome in lupus nephritisRobert F Spiera, Peter Homel, Harry Spiera
Arthritis and Rheumatism|April 11, 2003
Vision loss in giant cell arteritis patients treated with alternate-day corticosteroids: comment on the article by Hoffman et alRobert F Spiera, Mark Kupersmith, Stephen Paget, et al.
Clinical and Experimental Rheumatology|May 24, 2014
Practice patterns of ANCA-associated vasculitis: exploring differences among subspecialties at a single academic medical centreLindsy J Forbess, Kenneth W Griffin, Robert F Spiera
Arthritis Care & Research|October 10, 2014
Effectiveness of rituximab for the otolaryngologic manifestations of granulomatosis with polyangiitis (Wegener's)Lindsay Lally, Robert S Lebovics, Wei-Ti Huang, et al.
Archives of Internal Medicine|October 24, 2002
Ticlopidine-induced lupus: a report of 4 casesRobert F Spiera, Rosanne S Berman, Andrew J Werner, et al.
Pageof 7